Category Archives: Yaz / Yasmin
Actos Whistleblower Lawsuit Questions Avandia Researcher's Financial Ties to Takeda
A prominent researcher has been implicated in an alleged cover-up of Actos side effects, according to a report from TheHeart.org. An Actos whistleblower lawsuit unsealed earlier this year has alleged financial connections between the Cleveland Clinic’s Dr Steven Nissen and the maker of Actos “should be considered when analyzing Actos’s ...
Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk
Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year faced an increased risk of bladder cancer. Health Canada also ...
National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat
A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...
Smith & Nephew Says Metal-on-Metal Hip Replacement Controversy Slowing Sales of Birmingham Hip Resurfacing System
Medical device maker Smith & Nephew has reported a drop in sales of its metal-on-metal hip implant devices. According to the company, hip implant sales were down 2 percent during the first quarter of 2012, largely because its Birmingham Hip Resurfacing System suffered from an association with other metal-on-metal hip ...
Bisphosphonate Study Confirms Atypical Thigh Fracture Risk
New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that the risk of atypical thigh fractures increases the longer a ...
Study Finds SSRI Antidepressant Side Effects Outweigh Their Benefits
A new study is raising more concerns about the safety of commonly used antidepressants, including selective serotonin reuptake (SSRI) inhibitor antidepressants. Investigators who conducted the study, which is published in the journal Frontiers in Psychology, posit that increased knowledge of the negative effects of SSRIs and other antidepressants could reduce ...
Lawsuit Alleges Bi-Lateral DePuy ASR Hip Implant Resulted in Elevated Chromium and Cobalt Levels, Need for Revision Surgery
DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be named in lawsuits by metal-on-metal hip replacement recipients who suffered severe injuries, including elevated chromium and cobalt levels, allegedly due to recalled ASR hip implant devices. Most recently, the national law firm of Parker Waichman LLP filed suit on ...
First Bard Avaulta Transvaginal Mesh Lawsuit Scheduled for February Trial in MDL
The first test trials in the federal C.R. Bard Avaulta transvaginal mesh litigation will most likely start next year, according to a report from Bloomberg News. About 600 lawsuits involving Bard Avaulta transvaginal mesh products are currently pending in the multidistrict litigation underway Charleston, West Virginia. U.S. District Judge Joseph ...
1,000+ Australians Join DePuy ASR Hip Implant Class Action Lawsuit
A class action lawsuit filed in Australia over DePuy Orthopaedics’ recalled metal-on-metal ASR Hip Implants has signed up more than 1,000 plaintiffs. The attorneys representing the Australian ASR Hip Implant lawsuit plaintiffs recently told The Courier-Mail that damages in the lawsuit are expected to be worth more than $200 million. One ...
New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions
Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...
Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $142 Million
Bayer AG reported yesterday that it continues to settle Yaz and Yasmin birth control pill lawsuits. According to a report from Bloomberg News, the company said in its latest Stockholder Newsletter that it has settled 651 Yaz and Yasmin blood … Continue reading
Bayer Reportedly Settles Hundreds of Yaz, Yasmin Blood Clot Lawsuits
Bayer AG, the maker of Yaz and Yasmin birth control pills, has agreed to settle roughly 500 lawsuits alleging the contraceptives caused serious blood clots, some of which led to heart attacks and strokes. According to Bloomberg News, the settlements … Continue reading
Yaz, Yasmin Labels Being Updated with Info on Blood Clot Studies, FDA Says
The U.S. Food & Drug Administration (FDA) announced today that it has completed its review of studies investigating the link between Yaz, Yasmin and other birth control pills that contain the synthetic progestin, drospirenone, and an increased risk of blood … Continue reading
Bayer Acknowledges 70 Yaz Side Effect Lawsuit Settlements
Bayer has reportedly settled something in the neighborhood of 70 Yaz side effect lawsuits. The Yaz lawsuits were filed by women who allegedly suffered blood clots, deep vein thrombosis, pulmonary embolism, strokes and other serious complications due to their use … Continue reading
Oral, Injectable Contraceptives May Raise Breast Cancer Risk, Lower Risk For Ovarian Cancer
A new study has found that birth control pills and injectable contraceptives may raise breast cancer risks and lower risks for ovarian cancer. The study reviewed women’s use of both injectable and oral birth control methods. While users of these … Continue reading
Health Concerns and Litigation over Yaz/Yasmin Birth Control
Bayer is being widely criticized over Yaz and Yasmin, two similar types of oral contraceptives. The popular birth control pills are reportedly responsible for causing blood-clots, with some instances resulting in death. In light of the evidence, advisors to the … Continue reading
Lawyers for Yaz, Yasmin Plaintiffs want to Present Evidence on FDA Conflicts
Lawyers representing thousands of women injured by the oral contraceptives Yaz or Yasmin have asked a federal judge overseeing consolidated litigation to not dismiss key evidence showing conflict-of-interest played a key role in a regulatory decision on the safety of … Continue reading
New FDA Yaz, Yasmin Hearing Sought Amid Conflict-of-Interest Concerns
A public advocacy group wants the U.S. Food & Drug Administration (FDA) to convene another advisory panel hearing on the safety of Yaz, Yasmin and other birth control pills containing the synthetic progestin, drospirenone. The Project on Government Oversight (POGO) … Continue reading
FDA Advisors who Backed Yaz, Yasmin had Ties to Bayer
Several of the outside experts who recently made safety recommendations for Yaz, Yasmin and other drospirenone birth control pills had ties to Bayer AG, the maker of the drugs. However, those ties were not disclosed to the public by the … Continue reading
First Yaz, Yasmin Test Trial Postponed, as Lawsuits Head to Mediation
The first bellwether trial in the federal Yaz and Yasmin product liability litigation has been postponed. According to a report from FiercePharma, U.S. District Court Judge David Herndon, who is overseeing the multidistrict litigation, has ordered the Yaz and Yasmin … Continue reading
